Exposure to depleted uranium does not alter the co-expression of HER-2/neu and p53 in breast cancer patients

BACKGROUND: Amongst the extensive literature on immunohistochemical profile of breast cancer, very little is found on populations exposed to a potential risk factor such as depleted uranium. This study looked at the immunohistochemical expression of HER-2/neu (c-erbB2) and p53 in different histologi...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Mumen, Mais M, Al-Janabi, Asad A, Jumaa, Alaa S, Al-Toriahi, Kaswer M, Yasseen, Akeel A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Project Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072333/
https://www.ncbi.nlm.nih.gov/pubmed/21443808
http://dx.doi.org/10.1186/1756-0500-4-87

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072333/
https://www.ncbi.nlm.nih.gov/pubmed/21443808
http://dx.doi.org/10.1186/1756-0500-4-87

Ejemplares similares